Candida Clinical Trials in Clermont-Ferrand
2 recruitingClermont-Ferrand, France
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC
PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy
Novartis Pharmaceuticals123 enrolled11 locationsNCT07226986
Recruiting
Not Applicable
Evaluation of the Implementation of a Diet Workshop on the 15th Postoperative Day Following Bariatric Surgery
Bariatric Surgery Candidate
University Hospital, Clermont-Ferrand88 enrolled1 locationNCT05695040